| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |